Skip to main content

Bahrain claims success with anti-malarial drug used on coronavirus patients

Bahrain says that hydroxychloroquine, an anti-malaria drug promoted by US President Donald Trump to treat COVID-19, was successful in treating coronavirus patients.

Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020.  REUTERS/Craig Lassig - RC2ANF97R1QI
Researchers at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of COVID-19, in Minneapolis, Minnesota, March 19, 2020. — REUTERS/Craig Lassig

The much-touted anti-malarial drug seen as a possible treatment for coronavirus has been used successfully in Bahrain, a top health official said Tuesday.

Bahrain, according to the state-run Bahrain News Agency, is one of the first countries to use the decades-old malaria drug known as hydroxychloroquine to treat coronavirus patients. The agency quotes Lt. Gen. Dr. Shaikh Mohammed bin Abdullah Al Khalifa, the head of the Bahrain’s coronavirus task force, who said hydroxychloroquine had been effective in “alleviating the symptoms of the virus and reducing its complications.” 

Related Topics

Subscribe for unlimited access

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more

$14 monthly or $100 annually ($8.33/month)
OR

Continue reading this article for free

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more.

By signing up, you agree to Al-Monitor’s Terms and Conditions and Privacy Policy. Already have an account? Log in